About JME GROUP ASSOCIATES INC
JME Group, Inc. is a privately held biotechnology company founded in 2014 in New Jersey, focused on developing oral enzyme replacement therapy (Oral-ERT) and non-viral gene replacement therapy for metabolic and lysosomal storage diseases, including Pompe disease.
Development of oral enzyme replacement therapy (Oral-ERT) using plant-derived recombinant human enzymesNon-viral gene replacement therapy for human and animal conditionsProduction of dietary supplement BARZYME for energy, muscle weakness, and weight maintenance
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to JME GROUP ASSOCIATES INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.